|
Volumn 208, Issue 2, 2004, Pages 135-137
|
Topical effectiveness of molgramostim (GM-CSF) in sickle cell leg ulcers
|
Author keywords
Molgramostim; Sickle cell leg ulcers; Treatment
|
Indexed keywords
RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
ADULT;
ARTICLE;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DISEASE DURATION;
DRUG EFFECT;
DRUG EFFICACY;
FEMALE;
HOMOZYGOSITY;
HUMAN;
LEG ULCER;
MALE;
PRIORITY JOURNAL;
SICKLE CELL ANEMIA;
SIDE EFFECT;
TREATMENT OUTCOME;
ULCER HEALING;
ADMINISTRATION, TOPICAL;
ADULT;
ANEMIA, SICKLE CELL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR;
HUMANS;
LEG ULCER;
MALE;
PROGNOSIS;
RECOMBINANT PROTEINS;
SAMPLING STUDIES;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
WOUND HEALING;
|
EID: 17444450057
PISSN: 10188665
EISSN: None
Source Type: Journal
DOI: 10.1159/000076487 Document Type: Article |
Times cited : (22)
|
References (7)
|